Clinical Trials Directory

Trials / Completed

CompletedNCT05358951

Sleep Treatment Education Program for Young Adult Cancer Survivors (STEP-YA)

Sleep Treatment Education Program for Young Adult Cancer Survivors (STEP-YA): An Online Educational Intervention for Insomnia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
56 (actual)
Sponsor
Dana-Farber Cancer Institute · Academic / Other
Sex
All
Age
20 Years – 39 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to learn if a single online education session, with or without individualized coaching sessions, can help improve young adult cancer survivors' (YACS) sleep. The name of the study intervention is Sleep Treatment Education Program for Young Adult Cancer Survivors (STEP-YA).

Detailed description

This study is a randomized controlled trial of young adult cancer survivors with clinically significant symptoms of insomnia to evaluate the cognitive-behavioral based Sleep Treatment Education Program for Young Adult Cancer Survivors (STEP-YA). All participants will take part in a single STEP-YA session, during which they will complete baseline measures prior to randomization and then receive the STEP-YA intervention. Participants will then be randomly assigned to receive the STEP-YA intervention either, 1) alone (non-coaching condition), or 2) with the addition of 2 remote coaching sessions (coaching condition). Participants will also complete follow-up measures 4 and 8 weeks post-baseline. It expected that about 74 people will take part in this study

Conditions

Interventions

TypeNameDescription
BEHAVIORALSTEP-YA with CoachingOnline instruction on behavioral changes to improve sleep with 2 additional individually coached session
BEHAVIORALSTEP-YA without CoachingOnline instruction on behavioral changes to improve sleep without additional individually coached session

Timeline

Start date
2022-11-19
Primary completion
2025-07-28
Completion
2025-07-28
First posted
2022-05-03
Last updated
2026-02-27
Results posted
2026-02-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05358951. Inclusion in this directory is not an endorsement.